Goodwin partner Laura Umbrecht Gulick has been announced as a Law360 Rising Star for 2025 in the Life Sciences category.
As one of the leading dealmakers in her field and a partner in Goodwin’s Life Sciences group, Laura regularly represents public and private pharmaceutical, biotechnology, pharma services and medical device companies and their investors. She has extensive experience working with many high-profile clients in the biotechnology and pharmaceutical sectors and has been pivotal in Goodwin’s expansion into the Philadelphia market.
Beyond her practice, Laura was named a 2024 Woman of Influence by the Philadelphia Business Journal. She was also recognized by Mergers & Acquisitions’ Most Influential Women in Mid-Market M&A 2025 as an Honorable Mention honoree.